Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

Completed · Phase 4 · Has a placebo group

Conditions studied: Allergic Rhinitis

In brief

The purpose of this study is to help us to a better understanding of how nose and eye symptoms are related in patients with allergies.

Key facts

Study ID

NCT00791973

Run by

University of Chicago

People needed

15

Starts

2008-11-01

Expected to finish

2010-05-01

Last updated by the study team

2014-07-08

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Males and females between 18 and 45 years of age.
• History of grass and/or ragweed allergic rhinitis.
• Positive skin test to grass and/or ragweed antigen.
• Positive response to screening nasal challenge.

You may not qualify if…

• Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
• Pregnant or lactating women.
• Upper respiratory infection within 14 days of study start.

Where it is running

• University of Chicago Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.